VYZULTA
VYZULTA
Approved
DIN Number
02484218
Drug Class
Human
Market Date
May 17, 2019
Company
HC
bausch & lomb inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02484218
AIG Number0161070001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01EE06 LATANOPROSTENE BUNOD
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic
AHFS Classification52:40.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
LATANOPROSTENE BUNODActive
Strength: 0.024 % / W/V
Monograph: LATANOPROSTENE BUNOD